β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Ratios
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Current Ratio | Quick Ratio | Cash Ratio | Days Of Sales Outstanding | Days Of Inventory Outstanding | Operating Cycle | Days Of Payables Outstanding | Cash Conversion Cycle | Gross Profit Margin | Operating Profit Margin | Pretax Profit Margin | Net Profit Margin | Effective Tax Rate | Return On Assets | Return On Equity | Return On Capital Employed | Net Income Per EBT | EBT Per EBIT | EBIT Per Revenue | Debt Ratio | Debt/Equity Ratio | Long Term Debt To Capitalization | Total Debt To Capitalization | Interest Coverage | Cash Flow To Debt Ratio | Company Equity Multiplier | Receivables Turnover | Payables Turnover | Inventory Turnover | Fixed Asset Turnover | Asset Turnover | Operating Cash Flow Per Share | Free Cash Flow Per Share | Cash Per Share | Payout Ratio | Operating Cash Flow / Sales Ratio | Free Cash Flow / Operating Cash Flow Ratio | Cash Flow Coverage Ratio | Short Term Coverage Ratios | Capital Expenditure Coverage Ratio | Dividend Paid And CAPEX Coverage Ratio | Dividend Payout Ratio | Price Book Value Ratio | Price To Book Ratio | Price To Sales Ratio | Price Earnings Ratio | Price To Free Cash Flows Ratio | Price To Operating Cash Flows Ratio | Price Cash Flow Ratio | Price Earnings To Growth Ratio | Price Sales Ratio | Dividend Yield | Enterprise Value Multiple | Price Fair Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 0.89 | 0.76 | 0.33 | 54.02 | 41.43 | 95.46 | 53.38 | 42.08 | 0.48 | 0.26 | 0.26 | 0.2 | 0.23 | 0.08 | 0.17 | 0.13 | 0.75 | 1.01 | 0.26 | 0.27 | 0.57 | 0.29 | 0.36 | 33.73 | 0.44 | 2.1 | 6.76 | 6.84 | 8.81 | 1.28 | 0.41 | 19.68 | 10.29 | 10.13 | 0.4 | 0.29 | 0.52 | 0.44 | 1.5 | 2.1 | 1.32 | 0.4 | 5.26 | 5.26 | 6.07 | 30.53 | 40.69 | 21.27 | 21.27 | 3.84 | 6.07 | 0.01 | 17.04 | 5.26 |
2023-12 | 0.8 | 0.67 | 0.3 | 56.57 | 44.13 | 100.7 | 63.02 | 37.69 | 0.47 | 0.24 | 0.24 | 0.19 | 0.23 | 0.08 | 0.16 | 0.12 | 0.78 | 1 | 0.24 | 0.25 | 0.51 | 0.25 | 0.34 | 19.43 | 0.46 | 2.03 | 6.45 | 5.79 | 8.27 | 1.29 | 0.41 | 19.06 | 11.3 | 9.55 | 0.4 | 0.28 | 0.59 | 0.46 | 1.56 | 2.46 | 1.48 | 0.4 | 5.05 | 5.05 | 6.1 | 32.34 | 36.34 | 21.55 | 21.55 | 0.61 | 6.1 | 0.01 | 17.69 | 5.05 |
2022-12 | 0.79 | 0.67 | 0.33 | 53.69 | 37.12 | 90.81 | 56.2 | 34.61 | 0.42 | 0.16 | 0.17 | 0.12 | 0.26 | 0.05 | 0.1 | 0.08 | 0.75 | 1.03 | 0.16 | 0.22 | 0.45 | 0.23 | 0.31 | 85.22 | 0.49 | 1.99 | 6.8 | 6.49 | 9.83 | 1.42 | 0.42 | 17.74 | 11.39 | 10.88 | 0.57 | 0.27 | 0.64 | 0.49 | 1.55 | 2.79 | 1.61 | 0.57 | 4.07 | 4.07 | 4.89 | 39.31 | 28.64 | 18.39 | 18.39 | 3.23 | 4.89 | 0.01 | 16.16 | 4.07 |
2021-12 | 0.74 | 0.62 | 0.21 | 57.24 | 36.06 | 93.3 | 72.88 | 20.41 | 0.43 | 0.16 | 0.17 | 0.12 | 0.25 | 0.05 | 0.09 | 0.07 | 0.75 | 1.02 | 0.16 | 0.17 | 0.32 | 0.2 | 0.24 | 64.73 | 0.68 | 1.85 | 6.38 | 5.01 | 10.12 | 1.18 | 0.38 | 18.81 | 12.84 | 5.46 | 0.57 | 0.32 | 0.68 | 0.68 | 3.39 | 3.15 | 1.84 | 0.57 | 4.07 | 4.07 | 5.82 | 46.8 | 26.97 | 18.41 | 18.41 | 0.84 | 5.82 | 0.01 | 18.79 | 4.07 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more ratios for Linde!
Sign up for free or log inπ Join now to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" at no cost